EDP Sciences logo
Authentification abonné
Rechercher
Menu
Accueil Tous les numéros Volume 34 / Numéro 1 (Janvier 2018) Med Sci (Paris), 34 1 (2018) 47-53 Références
Accès gratuit
Numéro
Med Sci (Paris)
Volume 34, Numéro 1, Janvier 2018
Page(s) 47 - 53
Section M/S Revues
DOI https://doi.org/10.1051/medsci/20183401013
Publié en ligne 31 janvier 2018
  1. Jamilloux Y, Henry T. Les inflammasomes: plates-formes de l'immunité innée. Med Sci (Paris) 2013; 29: 975-84. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  2. Kayagaki N, Stowe IB, Lee BL, et al. Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling. Nature 2015; 526: 666-71. [CrossRef] [PubMed] [Google Scholar]
  3. Cabon L, Martinez-Torres AC, Susin SA. La mort cellulaire programmée ne manque pas de vocabulaire. Med Sci (Paris) 2013; 29: 1117-24. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  4. Lu A, Magupalli VG, Ruan J, et al. Unified polymerization mechanism for the assembly of ASC-dependent inflammasomes. Cell 2014; 156: 1193-206. [CrossRef] [PubMed] [Google Scholar]
  5. Shinkai K, McCalmont TH, Leslie KS. Cryopyrin-associated periodic syndromes and autoinflammation. Clin Exp Dermatol 2008; 33: 1-9. [PubMed] [Google Scholar]
  6. Martinon F, Pétrilli V, Mayor A, et al. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 2006; 440: 237-41. [CrossRef] [PubMed] [Google Scholar]
  7. Vandanmagsar B, Youm YH, Ravussin A, et al. The NALP3/NLRP3 inflammasome instigates obesity-induced autoinflammation and insulin resistance. Nat Med 2011; 17: 179-88. [CrossRef] [PubMed] [Google Scholar]
  8. Youm Y-H, Grant RW, McCabe LR, et al. Canonical Nlrp3 inflammasome links systemic low grade inflammation to functional decline in aging. Cell Metab 2013; 18: 519-32. [CrossRef] [PubMed] [Google Scholar]
  9. Heneka MT, Kummer MP, Latz E. Innate immune activation in neurodegenerative disease. Nat Rev Immunol 2014; 14: 463-77. [CrossRef] [PubMed] [Google Scholar]
  10. Franchi L, Muñoz-Planillo R, Núñez G. Sensing and reacting to microbes via the inflammasomes. Nat Immunol 2012; 13: 325-32. [CrossRef] [PubMed] [Google Scholar]
  11. Dostert C, Pétrilli V. Amiante et inflammation, rôle de l'inflammasome. Med Sci (Paris) 2008; 24: 916-8. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  12. Elliott EI, Sutterwala FS. Initiation and perpetuation of NLRP3 inflammasome activation and assembly. Immunol Rev. 2015; 265: 35-52. [CrossRef] [PubMed] [Google Scholar]
  13. Gaidt MM, Ebert TS, Chauhan D, et al. Human monocytes engage an alternative inflammasome pathway. Immunity 2016; 44: 833-46. [CrossRef] [PubMed] [Google Scholar]
  14. Jamilloux Y, Lefeuvre L, Magnotti F, et al. Familial Mediterranean fever mutations are hypermorphic mutations that specifically decrease the activation threshold of the Pyrin inflammasome. Rheumatology 2017; doi: 10.1093/rheumatology/kex373. [Google Scholar]
  15. Bauernfeind FG, Horvath G, Stutz A, et al. Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J Immunol 2009; 183: 787-91. [CrossRef] [PubMed] [Google Scholar]
  16. Franchi L, Eigenbrod T, Núñez G. Cutting edge: TNF-alpha mediates sensitization to ATP and silica via the NLRP3 inflammasome in the absence of microbial stimulation. J Immunol 2009; 183: 792-6. [CrossRef] [PubMed] [Google Scholar]
  17. Gurung P, Anand PK, Malireddi RKS, et al. FADD and caspase-8 mediate priming and activation of the canonical and noncanonical Nlrp3 inflammasomes. J Immunol 2014; 192: 1835-46. [CrossRef] [PubMed] [Google Scholar]
  18. Zhang X, Fan C, Zhang H, et al. MLKL and FADD are critical for suppressing progressive lymphoproliferative disease and activating the NLRP3 inflammasome. Cell Rep 2016; 16: 3247-59. [CrossRef] [PubMed] [Google Scholar]
  19. Fernandes-Alnemri T, Kang S, Anderson C, et al. Cutting edge: TLR signaling licenses IRAK1 for rapid activation of the NLRP3 inflammasome. J Immunol 2013; 191: 3995-9. [CrossRef] [PubMed] [Google Scholar]
  20. Juliana C, Fernandes-Alnemri T, Kang S, et al. Non-transcriptional priming and deubiquitination regulate NLRP3 inflammasome activation. J Biol Chem 2012; 287: 36617-22. [CrossRef] [PubMed] [Google Scholar]
  21. Kang S, Fernandes-Alnemri T, Rogers C, et al. Caspase-8 scaffolding function and MLKL regulate NLRP3 inflammasome activation downstream of TLR3. Nat Commun 2015; 6: 7515. [CrossRef] [PubMed] [Google Scholar]
  22. Hernandez-Cuellar E, Tsuchiya K, Hara H, et al. Cutting edge: nitric oxide inhibits the NLRP3 inflammasome. J Immunol 2012; 189: 5113-7. [CrossRef] [PubMed] [Google Scholar]
  23. Rühl S, Broz P. Caspase-11 activates a canonical NLRP3 inflammasome by promoting K+ efflux. Eur J Immunol 2015; 45: 2927-36. [CrossRef] [PubMed] [Google Scholar]
  24. Solle M, Labasi J, Perregaux DG, et al. Altered cytokine production in mice lacking P2X(7) receptors. J Biol Chem 2001; 276: 125-32. [CrossRef] [PubMed] [Google Scholar]
  25. Hornung V, Bauernfeind F, Halle A, et al. Silica crystals and aluminum salts mediate NALP-3 inflammasome activation via phagosomal destabilization. Nat Immunol 2008; 9: 847-56. [CrossRef] [PubMed] [Google Scholar]
  26. Franklin BS, Bossaller L, De Nardo D, et al. The adaptor ASC has extracellular and prionoid activities that propagate inflammation. Nat Immunol 2014; 15: 727-37. [CrossRef] [PubMed] [Google Scholar]
  27. Baroja-Mazo A, Martín-Sánchez F, Gomez AI, et al. The NLRP3 inflammasome is released as a particulate danger signal that amplifies the inflammatory response. Nat Immunol 2014; 15: 738-48. [CrossRef] [PubMed] [Google Scholar]
  28. Zhou R, Yazdi AS, Menu P, et al. A role for mitochondria in NLRP3 inflammasome activation. Nature 2011; 469: 221-5. [CrossRef] [PubMed] [Google Scholar]
  29. Lee GS, Subramanian N, Kim AI, et al. The calcium-sensing receptor regulates the NLRP3 inflammasome through Ca2+ and cAMP. Nature 2012; 492: 123-7. [CrossRef] [PubMed] [Google Scholar]
  30. Muñoz-Planillo R, Kuffa P, Martínez-Colón G, et al. K+ efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter. Immunity 2013; 38: 1142-53. [CrossRef] [PubMed] [Google Scholar]
  31. Iyer SS, He Q, Janczy JR, et al. Mitochondrial cardiolipin is required for Nlrp3 inflammasome activation. Immunity 2013; 39: 311-23. [CrossRef] [PubMed] [Google Scholar]
  32. Nakahira K, Haspel JA, Rathinam VA, et al. Autophagy proteins regulate innate immune response by inhibiting NALP3 inflammasome-mediated mitochondrial DNA release. Nat Immunol 2011; 12: 222-30. [CrossRef] [PubMed] [Google Scholar]
  33. Song N, Liu ZS, Xue W, et al. NLRP3 Phosphorylation is an essential priming event for inflammasome activation. Mol Cell 2017; 68: 185-7. [CrossRef] [PubMed] [Google Scholar]
  34. Saito M, Fujisawa A, Nishikomori R, et al. Somatic mosaicism of CIAS1 in a patient with chronic infantile neurologic, cutaneous, articular syndrome. Arthritis Rheum 2005; 52: 3579-85. [CrossRef] [PubMed] [Google Scholar]
  35. Mayor A, Martinon F, De Smedt T, et al. A crucial function of SGT1 and HSP90 in inflammasome activity links mammalian and plant innate immune responses. Nat Immunol 2007; 8: 497-503. [CrossRef] [PubMed] [Google Scholar]
  36. Han S, Lear TB, Jerome JA, et al. Lipopolysaccharide primes the NALP3 inflammasome by inhibiting its ubiquitination and degradation mediated by the SCFFBXL2 E3 ligase. J Biol Chem 2015; 290: 18124-33. [CrossRef] [PubMed] [Google Scholar]
  37. Duong BH, Onizawa M, Oses-Prieto JA, et al. A20 restricts ubiquitination of pro-interleukin-1β protein complexes and suppresses NLRP3 inflammasome activity. Immunity 2015; 42: 55-67. [CrossRef] [PubMed] [Google Scholar]
  38. Py BF, Kim M-S, Vakifahmetoglu-Norberg H, et al. Deubiquitination of NLRP3 by BRCC3 critically regulates inflammasome activity. Mol Cell 2013; 49: 331-8. [CrossRef] [PubMed] [Google Scholar]
  39. Spalinger MR, Kasper S, Gottier C, et al. NLRP3 tyrosine phosphorylation is controlled by protein tyrosine phosphatase PTPN22. J Clin Invest 2016; 126: 1783-1800. [CrossRef] [PubMed] [Google Scholar]
  40. Frenkel J, Kempen MJA van, Kuis W, et al. Variant chronic infantile neurologic, cutaneous, articular syndrome due to a mutation within the leucine-rich repeat domain of CIAS1. Arthritis Rheum 2004; 50: 2719-20. [CrossRef] [PubMed] [Google Scholar]
  41. Stutz A, Kolbe CC, Stahl R, et al. NLRP3 inflammasome assembly is regulated by phosphorylation of the pyrin domain. J Exp Med 2017; 214: 1725-36. [CrossRef] [PubMed] [Google Scholar]
  42. He Y, Zeng MY, Yang D, et al. Nek7 is an essential mediator of NLRP3 activation downstream of potassium efflux. Nature 2016; 530: 354-7. [CrossRef] [PubMed] [Google Scholar]
  43. Zhang Z, Meszaros G, He WT, et al. Protein kinase D at the Golgi controls NLRP3 inflammasome activation. J Exp Med 2017; 214: 2671-93. [CrossRef] [PubMed] [Google Scholar]
  44. Guo C, Xie S, Chi Z, et al. Bile acids control inflammation and metabolic disorder through inhibition of NLRP3 inflammasome. Immunity 2016; 45: 802-16. [CrossRef] [PubMed] [Google Scholar]
  45. Mortimer L, Moreau F, MacDonald JA, et al. NLRP3 inflammasome inhibition is disrupted in a group of auto-inflammatory disease CAPS mutations. Nat Immunol 2016; 17: 1176-86. [CrossRef] [PubMed] [Google Scholar]
  46. Yan Y, Jiang W, Liu L, et al. Dopamine controls systemic inflammation through inhibition of NLRP3 inflammasome. Cell 2015; 160: 62-73. [CrossRef] [PubMed] [Google Scholar]
  47. Hara H, Tsuchiya K, Kawamura I, et al. Phosphorylation of ASC acts as a molecular switch controlling the formation of speck-like aggregates and inflammasome activity. Nat Immunol 2013; 14: 1247-55. [CrossRef] [PubMed] [Google Scholar]
  48. Labbé K, McIntire CR, Doiron K, et al. Cellular inhibitors of apoptosis proteins cIAP1 and cIAP2 are required for efficient caspase-1 activation by the inflammasome. Immunity 2011; 35: 897-907. [CrossRef] [PubMed] [Google Scholar]
  49. Rodgers MA, Bowman JW, Fujita H, et al. The linear ubiquitin assembly complex (LUBAC) is essential for NLRP3 inflammasome activation. J Exp Med 2014; 211: 1333-47. [CrossRef] [PubMed] [Google Scholar]
  50. Shi CS, Shenderov K, Huang NN, et al. Activation of autophagy by inflammatory signals limits IL-1β production by targeting ubiquitinated inflammasomes for destruction. Nat Immunol 2012; 13: 255-63. [CrossRef] [PubMed] [Google Scholar]
  51. Song H, Liu B, Huai W, et al. The E3 ubiquitin ligase TRIM31 attenuates NLRP3 inflammasome activation by promoting proteasomal degradation of NLRP3. Nat Commun 2016; 7: 13727. [CrossRef] [PubMed] [Google Scholar]
  52. Mishra BB, Rathinam VAK, Martens GW, et al. Nitric oxide controls the immunopathology of tuberculosis by inhibiting NLRP3 inflammasomedependent processing of IL-1β. Nat Immunol 2013; 14: 52-60. [CrossRef] [PubMed] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.